A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease | Nephrology Now
Links shared publicly online about this topic.
- 1,629total visits
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease | Nephrology Now
TREAT: RCT of diabetic CKD patients with anemia, comparing darbepoietin alfa at Hb 110 g/dL vs 90 g/dL. Primary endpoint not reduced and stroke rates increased.
View full resource at nephrologynow.com
Tags: Anemia Medication, Diabetes, Type 2 Diabetes, Urinary System, End-Stage Renal Disease, Aranesp, Chronic Kidney Disease
Most Recently Shared on November 3, 2009 at 4:52 pm By:
RT @nephrologynow Due to the potential implications of the TREAT study, mailout sent in advance of the full issue http://bit.ly/TREAT
Advertisement
